Various mechanistic pathways representing the aging process are altered in COPD

Chest

Volumn 149, Issue 1, 2016, Pages 53-61

  Rutten, Erica P A ^a   Gopal, Poornima ^a   Wouters, Emiel F M ^a   Franssen, Frits M E ^a   Hageman, Geja J ^b   Vanfleteren, Lowie E ^b   Spruit, Martijn A ^b   Reynaert, Niki L ^b  

^a Centre of Expertise for Chronic Organ Failure   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

COPD; Inflammation; Metabolism

Indexed keywords

KLOTHO PROTEIN; KU ANTIGEN; PROTEIN P16; PROTEIN P21; SIRTUIN 1; TELOMERIC REPEAT BINDING FACTOR 2; BETA GLUCURONIDASE; BIOLOGICAL MARKER; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; SIRT1 PROTEIN, HUMAN;

ACCELERATED AGING; ADULT; AGING; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA REPAIR; FEMALE; GENE EXPRESSION; HUMAN; INFLAMMATION; LEUKOCYTE; LEUKOCYTE TELOMERE LENGTH; LUNG FUNCTION; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; SENESCENCE; SMOKING; TELOMERE; AGED; CASE CONTROL STUDY; COMPLICATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; TELOMERE HOMEOSTASIS;

AGED; AGING; BIOMARKERS; CASE-CONTROL STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA REPAIR; FEMALE; GLUCURONIDASE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SIRTUIN 1; SMOKING; TELOMERE HOMEOSTASIS;

EID: 84954175011     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.15-0645     Document Type: Article

References (35)

1. Lpez-Otn C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194-1217
2. Meiners S, Eickelberg O, Knigshoff M. Hallmarks of the ageing lung. Eur Respir J. 2015;45(3):807-827
3. Ito K, Barnes PJ. COPD as a disease of accelerated lung aging. Chest. 2009;135(1): 173-180
4. Jha P, Peto R. Global effects of smoking, of quitting, and of taxing tobacco. N Engl J Med. 2014;370(1):60-68
5. Patel BD, Loo WJ, Tasker AD, et al. Smoking related COPD and facial wrinkling: is there a common susceptibility? Thorax. 2006;61(7): 568-571
6. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest. 2007; 131(5):1557-1566
7. Amsellem V, Gary-Bobo G, Marcos E, et al. Telomere dysfunction causes sustained inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;184(12): 1358-1366
8. Tsuji T, Aoshiba K, Nagai A. Alveolar cell senescence in patients with pulmonary emphysema. Am J Respir Crit Care Med. 2006;174(8):886-893
9. Tsuji T, Aoshiba K, Nagai A. Alveolar cell senescence exacerbates pulmonary inflammation in patients with chronic obstructive pulmonary disease. Respiration. 2010;80(1):59-70
10. Rajendrasozhan S, Yang SR, Kinnula VL, Rahman I. SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177(8):861-870
11. Rode L, Bojesen SE, Weischer M, Vestbo J, Nordestgaard BG. Short telomere length, lung function and chronic obstructive pulmonary disease in 46, 396 individuals. Thorax. 2013;68(5):429-435
12. Savale L, Chaouat A, Bastuji-Garin S, et al. Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;179(7): 566-571
13. Houben JM, Mercken EM, Ketelslegers HB, et al. Telomere shortening in chronic obstructive pulmonary disease. Respir Med. 2009;103(2):230-236
14. Lee J, Sandford A, Man P, Sin DD. Is the aging process accelerated in chronic obstructive pulmonary disease? Curr Opin Pulm Med. 2011;17(2):90-97
15. Mezzinler A, Zaineddin AK, Brenner H. A systematic review of leukocyte telomere length and age in adults. Ageing Res Rev. 2013;12(2):509-519
16. Houben JM, Giltay EJ, Rius-Ottenheim N, Hageman GJ, Kromhout D. Telomere length and mortality in elderly men: the Zutphen Elderly Study. J Gerontol A Biol Sci Med Sci. 2011;66(1):38-44
17. Albrecht E, Sillanp E, Karrasch S, et al. Telomere length in circulating leukocytes is associated with lung function and disease. Eur Respir J. 2014;43(4):983-992
18. Renzoni E, Srihari V, Sestini P. Pathogenesis of idiopathic pulmonary fibrosis: review of recent findings. F1000Prime Rep. 2014;6:69
19. Paschalaki KE, Starke RD, Hu Y, et al. Dysfunction of endothelial progenitor cells from smokers and chronic obstructive pulmonary disease patients due to increased DNA damage and senescence. Stem Cells. 2013;31(12): 2813-2826
20. Ito K, Colley T, Mercado N. Geroprotectors as a novel therapeutic strategy for COPD, an accelerating aging disease. Int J Chron Obstruct Pulmon Dis. 2012;7:641-652
21. Drmaku-Sopjani M, Kolgeci S, Abazi S, Sopjani M. Significance of the anti-Aging protein Klotho. Mol Membr Biol. 2013;30(8):369-385
22. Kuro-o M. Klotho and aging. Biochim Biophys Acta. 2009;1790(10):1049-1058
23. Brown JP, Wei W, Sedivy JM. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science. 1997;277(5327): 831-834
24. Herbig U, Jobling WA, Chen BP, Chen DJ, Sedivy JM. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell. 2004;14(4):501-513
25. Chai W, Ford LP, Lenertz L, Wright WE, Shay JW. Human Ku70/80 associates physically with telomerase through interaction with hTERT. J Biol Chem. 2002;277(49):47242-47247
26. Fink LS, Lerner CA, Torres PF, Sell C. Ku80 facilitates chromatin binding of the telomere binding protein, TRF2. Cell Cycle. 2010;9(18):3798-3806
27. Opresko PL, Fan J, Danzy S, Wilson DM, Bohr VA. Oxidative damage in telomeric DNA disrupts recognition by TRF1 and TRF2. Nucleic Acids Res. 2005;33(4):1230-1239
28. Indiviglio SM, Bertuch AA. Kus essential role in keeping telomeres intact. Proc Natl Acad Sci USA. 2009;106(30):12217-12218
29. Lieber MR, Karanjawala ZE. Ageing, repetitive genomes and DNA damage. Nat Rev Mol Cell Biol. 2004;5(1):69-75
30. Morita A. Tobacco smoke causes premature skin aging. J Dermatol Sci. 2007;48(3):169-175
31. Babizhayev MA, Vishnyakova KS, Yegorov YE. Oxidative damage impact on aging and age-related diseases: drug targeting of telomere attrition and dynamic telomerase activity flirting with imidazole-containing dipeptides. Recent Pat Drug Deliv Formul. 2014;8(3): 163-192
32. Agust A, Edwards LD, Rennard SI, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS ONE. 2012;7(5):e37483
33. Boldyrev AA, Yuneva MO, Sorokina EV, et al. Antioxidant systems in tissues of senescence accelerated mice. Biochemistry. 2001;66(10):1157-1163
34. Cai W, He JC, Zhu L, et al. Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression. Am J Pathol. 2007;170(6): 1893-1902
35. Thannickal VJ, Murthy M, Balch WE, et al. Blue journal conference. Aging and susceptibility to lung disease. Am J Respir Crit Care Med. 2015;191(3):261-269